News

Orforglipron, an oral GLP-1 receptor agonist developed by Eli Lilly, has shown positive Phase 3 results in treating type 2 ...
Wellness startups are launching products that target the natural growth of GLP-1, the hormone that medicines like Ozempic and ...
One of the foremost hurdles encountered in the pursuit of weight loss is the apprehension of physical exhaustion and the ...
In the same way Ozempic has obliterated the body positivity movement, new “undetectable” cosmetic interventions are creating ...
Other weight loss drugs must be injected, meaning the new pill from pharmaceutical giant Eli Lilly could become patients’ top ...
Oleocanthal and oleoresin are compounds in extra virgin olive oil that may help reduce inflammation and pain. Experts are now ...
Pratyush Vatsala, the principal of Delhi University, posted a video showing her plastering the manure onto the walls with her ...